KURE

KraneShares MSCI All China Health Care Index ETF · PSE

  • Category Health Care
  • Expense Ratio 0.65%
  • Listing Date Feb 01, 2018
  • Volume 7,675.0
  • Market Cap (AUM) $104.15M

Performance

+3.03%

1W

+8.07%

1M

+6.42%

3M

+19.59%

6M

+10.35%

YTD

+1.49%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A3007609.43%
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A6002767.05%
  • BeiGene Ltd61605.17%
  • CSPC Pharmaceutical Group Limited10934.52%
  • Wuxi Biologics (Cayman) Inc.22693.60%
  • Innovent Biologics, Inc.18013.60%
  • Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A6004363.50%
  • WuXi AppTec Co., Ltd. Class A6032592.83%
  • Aier Eye Hospital Group Co., Ltd. Class A3000152.82%
  • Yunnan Baiyao Group Co. Ltd. Class A0005382.54%

Technical Analysis of KURE 2025-03-14

The stock exhibits a strong bullish sentiment with a Moving Average Score of 100, indicating robust upward momentum, while the Technical Score of 75 further supports this positive outlook. However, the Oscillators Score of 50 suggests a neutral stance, indicating potential consolidation or indecision in the market.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.